228 related articles for article (PubMed ID: 31226865)
41. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
42. Poly(lactic-co-glycolic) Acid/Solutol HS15-Based Nanoparticles for Docetaxel Delivery.
Cho HJ; Park JH; Kim DD; Yoon IS
J Nanosci Nanotechnol; 2016 Feb; 16(2):1433-6. PubMed ID: 27433600
[TBL] [Abstract][Full Text] [Related]
43. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells.
Patel J; Amrutiya J; Bhatt P; Javia A; Jain M; Misra A
J Microencapsul; 2018 Mar; 35(2):204-217. PubMed ID: 29542378
[TBL] [Abstract][Full Text] [Related]
44. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer.
Verma P; Meher JG; Asthana S; Pawar VK; Chaurasia M; Chourasia MK
Drug Deliv; 2016; 23(2):479-88. PubMed ID: 24901205
[TBL] [Abstract][Full Text] [Related]
45. Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.
Palma G; Conte C; Barbieri A; Bimonte S; Luciano A; Rea D; Ungaro F; Tirino P; Quaglia F; Arra C
Int J Pharm; 2014 Oct; 473(1-2):55-63. PubMed ID: 24992317
[TBL] [Abstract][Full Text] [Related]
46. Tumour targeted polymer nanoparticles co-loaded with docetaxel and siCCAT2 for combination therapy of lung cancer.
Xiao D; Hu X; Zhang J
J Drug Target; 2022 Jun; 30(5):534-543. PubMed ID: 34931561
[TBL] [Abstract][Full Text] [Related]
47. [Preparation of docetaxel-loaded nanomicelles and their anti-Lewis lung cancer effect in vitro].
Wang YJ; Wang J; Hao DL; Yue QX; Xie R; DE GJ; Yi H; Zang C; Zhao QH; Chen YJ
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2251-2259. PubMed ID: 31359650
[TBL] [Abstract][Full Text] [Related]
48. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy.
Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G
AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689
[TBL] [Abstract][Full Text] [Related]
49. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery.
Yuan Z; Gu X
Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633
[TBL] [Abstract][Full Text] [Related]
50. Targeting docetaxel-PLA nanoparticles simultaneously inhibit tumor growth and liver metastases of small cell lung cancer.
Liang Z; Yang N; Jiang Y; Hou C; Zheng J; Shi J; Zhang R; Li D; Liu Y; Zuo P
Int J Pharm; 2015 Oct; 494(1):337-45. PubMed ID: 26299762
[TBL] [Abstract][Full Text] [Related]
51. Folate-Functionalized Thiomeric Nanoparticles for Enhanced Docetaxel Cytotoxicity and Improved Oral Bioavailability.
Sajjad M; Khan MI; Naveed S; Ijaz S; Qureshi OS; Raza SA; Shahnaz G; Sohail MF
AAPS PharmSciTech; 2019 Jan; 20(2):81. PubMed ID: 30645705
[TBL] [Abstract][Full Text] [Related]
52. Docetaxel-loaded PLGA nanoparticles to increase pharmacological sensitivity in MDA-MB-231 and MCF-7 breast cancer cells.
Tran P; Nguyen TN; Lee Y; Tran PN; Park JS
Korean J Physiol Pharmacol; 2021 Sep; 25(5):479-488. PubMed ID: 34448465
[TBL] [Abstract][Full Text] [Related]
53. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
[TBL] [Abstract][Full Text] [Related]
54. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
55. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M
J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681
[TBL] [Abstract][Full Text] [Related]
56. Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer.
Tian J; Min Y; Rodgers Z; Wan X; Qiu H; Mi Y; Tian X; Wagner KT; Caster JM; Qi Y; Roche K; Zhang T; Cheng J; Wang AZ
Nanomedicine; 2017 Apr; 13(3):1301-1307. PubMed ID: 27884641
[TBL] [Abstract][Full Text] [Related]
57. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
58. Excipient selection and aerodynamic characterization of nebulized lipid-based nanoemulsion loaded with docetaxel for lung cancer treatment.
Asmawi AA; Salim N; Ngan CL; Ahmad H; Abdulmalek E; Masarudin MJ; Abdul Rahman MB
Drug Deliv Transl Res; 2019 Apr; 9(2):543-554. PubMed ID: 29691812
[TBL] [Abstract][Full Text] [Related]
59. Formulation of a Sustained Release Docetaxel Loaded Cockle Shell-Derived Calcium Carbonate Nanoparticles against Breast Cancer.
Hammadi NI; Abba Y; Hezmee MNM; Razak ISA; Jaji AZ; Isa T; Mahmood SK; Zakaria MZAB
Pharm Res; 2017 Jun; 34(6):1193-1203. PubMed ID: 28382563
[TBL] [Abstract][Full Text] [Related]
60. Design of Lamivudine Loaded Nanoparticles for Oral Application by Nano Spray Drying Method: A New Approach to use an Antiretroviral Drug for Lung Cancer Treatment.
Öztürk AA; Namlı İ; Güleç K; Görgülü Ş
Comb Chem High Throughput Screen; 2020; 23(10):1064-1079. PubMed ID: 32209039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
